Population aging is one of Europe’s great challenges in the 21st century. By 2024, 22% of Europeans are expected to be over 65. Patients suffering from chronic joint detop fects or defects in the oral and maxillofacial regions have a significantly reduced quality of life and are continually dependent on health care. The Covid-19 crisis has shown how dangerous chronically overcrowded hospitals and large cohorts of care-dependent and risk-grouped patients can become. Therefore, science and technology must work together to ensure that living longer can be synonymous with living well. INKplant, a project funded by the European Union H2020, was conceived to face this challenge and democratize its new solutions.